期刊的影响因子--文章列表

期刊文章列表
Rilan Bai，Naifei Chen，Xiao Chen，Lingyu Li，Wei Song，Wei Li，Yuguang Zhao，Yongfei Zhang，Fujun Han，Zheng Lyu，Jiuwei Cui（Cancer Center,the First Hospital of Jilin University）.Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events[J].Cancer Biology & Medicine,2021,第4期 Kazuma Kiyotani，Yujiro Toyoshima，Yusuke Nakamura（Project for Immunogenomics,Cancer Precision Medicine Center,Japanese Foundation for Cancer Research）.Personalized immunotherapy in cancer precision medicine[J].Cancer Biology & Medicine,2021,第4期 Xiangdong Ye^1,2，Xueqing Wang¹，Wenhui Yu¹，Qing Yang¹，Yan Li¹，Yanxia Jin³，Yanting Su¹，Jiaqi Song¹，Bo Xu¹，Hui Sun^1,4（College of Life Sciences,Wuhan University；Department of Biochemistry and Molecular Biology,Institute of Biomedical research,College of Basic Medicine,Hubei University of Medicine；Hubei Key Laboratory of Edible Wild Plants Conservation and Utilization,Hubei Normal University；Hubei Province key Laboratory of Allergy and Immunology，Wuhan University）.Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver[J].Cancer Biology & Medicine,2021,第4期 Chen Zhang¹，Jie Yin²，Jian Zheng²，Jun Xiao²，Jiajian Hu³，Yudong Su³，Kaichen Zhou²，Yingchi Zhang^4,5，Xuzhen Zhang⁶，Hong Zhang²，Qian Sun¹，Yang Wang¹，Wenwen Yu¹，Feng Wei¹，Qiang Zhao³，Long Li^2,3，Xiubao Ren¹（Department of Immunology and Biotherapy,Key Laboratory of Cancer Immunology and Biotherapy,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy，Tianjin,Tianjin's Clinical Research Center for Cancer；Department of Immunology,Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education,Tianjin Medical University；Department of Pediatric Cancer,Tianjin Medical University Cancer Institute and Hospital；State Key Laboratory of Experimental Hematology and Division of Pediatric Blood Diseases Center,Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Center for Stem Cell Medicine,Chinese Academy of Medical Sciences；Research Center of Basic Medicine Science,Tianjin Medical University）.EZH2 identifies the precursors of human natural killer cells with trained immunity[J].Cancer Biology & Medicine,2021,第4期 Weihong Zhang¹，Yuan Meng¹，Lin Yang²，Meng Shen¹，Li Zhou¹，Runmei Li¹，Yang Wang¹，Weijiao Du¹，Yanjuan Xiong¹，Ying Han¹，Xinwei Zhang¹，Liang Liu¹，Xiubao Ren¹（Department of Immunology and Biotherapy,Key Laboratory of Cancer Immunology and Biotherapy,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy，Tianjin,Tianjin's Clinical Research Center for Cancer；State Key Laboratory of Experimental Hematology,Peking Union Medical College,Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Sciences）.Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events[J].Cancer Biology & Medicine,2021,第4期 Hongchao Tang¹，Hao Li¹，Zhijun Sun^1,2（The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education,School & Hospital of Stomatology,Wuhan University；Department of Oral and Maxillofacial Head Neck Surgery,School & Hospital of Stomatology,Wuhan University）.Targeting myeloid-derived suppressor cells for cancer therapy[J].Cancer Biology & Medicine,2021,第4期 Zhe Gong^1,2，Yue Yang^1,2，Jieyun Zhang^1,2，Weijian Guo^1,2（Department of Medical Oncology,Fudan University Shanghai Cancer Center；Department of Oncology,Shanghai Medical College,Fudan University）.Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types[J].Cancer Biology & Medicine,2021,第4期 Ping Li，Fengyang Chen，Jingbin Zheng，Yang Yang，Yuan Li，Yifei Wang，Xin Chen（State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Science,University of Macau）.Cyclophosphamide abrogates the expansion of CD4⁺Foxp3⁺regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas[J].Cancer Biology & Medicine,2021,第4期 Lu Han¹，Jian Zhou²，Linlin Li³，Keshu Zhou²，Lingdi Zhao¹，Xinghu Zhu²，Qingsong Yin²，Yufu Li²，Hongqin You¹，Jishuai Zhang⁴，Yongping Song²，Quanli Gao¹（Department of Immunology，Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital；Department of Hematology,Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital；Department of Medical Microbiology,School of Basic Medical Sciences,Xinxiang Medical University；The Shenzhen Pregene Biopharma Company,Ltd.）.Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies[J].Cancer Biology & Medicine,2021,第4期 Hua Zhao¹，Hao Wang¹，Qiuru Zhou¹，Xiubao Ren^1,2（Department of Immunology，Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy，Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Immunology and Biotherapy；Department of Biotherapy,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy，Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Immunology and Biotherapy）.Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies[J].Cancer Biology & Medicine,2021,第4期 Qiaozhen Wu¹，Yuhui Huang^1,2（Suzhou Ninth Hospital Affiliated to Soochow University；Hematology Center,Cyrus Tang Medical Institute,The Collaborative Innovation Center of Hematology,State Key Laboratory of Radiation Medicine and Protection，Soochow University）.The role of DLL1 in long-term vascular normalization and cancer immunotherapy[J].Cancer Biology & Medicine,2021,第4期 Huihui Yin¹，Lu Yang²，Gongxin Peng³，Ke Yang⁴，Yuling Mi⁵，Xingsheng Hu²，Xuezhi Hao²，Yuchen Jiao¹，Xiaobing Wang¹，Yan Wang²（State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Center for Bioinformatics,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences & School of Basic Medicine,Peking Union Medical College；Department of Medical Oncology,Cancer Hospital of Huanxing Chaoyang District Beijing；Department of Medical Oncology,Chaoyang Sanhuan Cancer Hospital）.The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms[J].Cancer Biology & Medicine,2021,第4期 Junlei Zhang，Jinyuan Song，Jianpeng Sheng，Xueli Bai，Tingbo Liang（Department of Hepatobiliary and Pancreatic Surgery，Zhejiang Provincial Key Laboratory of Pancreatic Disease,the First Affiliated Hospital,Zhejiang University School of Medicine，Zhejiang University Cancer Centre,Zhejiang University）.Multiplex imaging reveals the architecture of the tumor immune microenvironment[J].Cancer Biology & Medicine,2021,第4期 Yingyan Yu（Department of General Surgery,Ruijin Hospital,Shanghai Institute of Digestive Surgery,Shanghai Key Laboratory for Gastric Neoplasms,Shanghai Jiao Tong University School of Medicine）.Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers[J].Cancer Biology & Medicine,2021,第4期 Zhengli Xu，Xiaojun Huang（Peking University People’s Hospital,Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation）.Cellular immunotherapy for hematological malignancy:recent progress and future perspectives[J].Cancer Biology & Medicine,2021,第4期 Yunfan Sun，Jian Zhou，Jia Fan，Xinrong Yang（Department of Liver Surgery & Transplantation,Liver Cancer Institute,Zhongshan Hospital,Fudan University，Key Laboratory of Carcinogenesis and Cancer Invasion,Ministry of Education）.Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells[J].Cancer Biology & Medicine,2021,第4期 Huahui Yu¹，Jieyu Li^2,3，Yuan Yuan^4,5，Yu Chen^3,6，Jingwen Hong¹，Chunmei Ye¹，Wansong Lin^2,3，Huijing Chen^2,3，Zengqing Guo^3,6，Bo Li⁴，Yunbin Ye^1,2,3（The School of Basic Medical Sciences,Fujian Medical University；Laboratory of Immuno-Oncology，Fujian Cancer Hospital & Fujian Medical University Cancer Hospital；Fujian Key Laboratory of Translational Cancer Medicine；BGI-Shenzhen；BGI Education Center，University of Chinese Academy of Sciences；Department of Oncology,Fujian Cancer Hospital &Fujian Medical University Cancer Hospital）.Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers[J].Cancer Biology & Medicine,2021,第4期 Jian Wang¹，Fan Yang²，Qian Sun¹，Ziqing Zeng¹，Min Liu¹，Wenwen Yu¹，Peng Zhang¹，Jinpu Yu³，Lili Yang¹，Xinwei Zhang²，Xiubao Ren^1,2，Feng Wei¹（Department of Immunology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy，Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Immunology and Biotherapy；Department of Biotherapy,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy，Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Immunology and Biotherapy；Cancer Molecular Diagnostics Core，Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy，Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Immunology and Biotherapy）.The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma[J].Cancer Biology & Medicine,2021,第4期 Ruining Gong¹，Yan Huang²，Xiaoxuan Wang¹，Xiaobing Chen³，Zibin Tian⁴，He Ren¹（Department of Gastroenterology,Center of Tumor Immunology and Cytotherapy,Medical Research Center of The Affiliated Hospital of Qingdao University；Department of Human Resources,The Affiliated Hospital of Qingdao University；Department of Oncology,The Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital；Department of Gastroenterology,The Affiliated Hospital of Qingdao University）.Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy[J].Cancer Biology & Medicine,2021,第4期 Xiubao，Ren（Department of Immunology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer；Department of Biotherapy,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer；Key Laboratory of Cancer Prevention and Therapy,Tianjin’s Clinical Research Center for Cancer,Key Laboratory of Cancer Immunology and Biotherapy）.Cancer immunology and immunotherapy[J].Cancer Biology & Medicine,2021,第4期 ShaoyuanLei，RongshouZheng，SiweiZhang，RuChen，ShaomingWang，KexinSun，HongmeiZeng，WenqiangWei，JieHe（Office for Cancer Registry,National Cancer Center，National Clinical Research Center for Cancer，Cancer Hospital,Chinese Academy of Medical Science and Peking Union Medical College；Department of Thoracic Surgery，National Cancer Center，National Clinical Research Center for Cancer，Cancer Hospital,Chinese Academy of Medical Science and Peking Union Medical College）.Breast cancer incidence and mortality in women in China:temporal trends and projections to 2030[J].Cancer Biology & Medicine,2021,第3期 NanlinHu，YiranSi，JianYue，TingtingSun，XueWang，ZhuqingJia，SonglinGao，QiaoLi，YangShao，JiayuWang，YangLuo，FeiMa，BingheXu，PengYuan（Department of Medical Oncology,National Cancer Center，National Clinical Research Center for Cancer，Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of VIP Medical Services,National Cancer Center，National Clinical Research Center for Cancer，Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Nanjing Geneseeq Technology Inc.；Cancer Hospital of Huanxing Chaoyang District Beijing）.Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer[J].Cancer Biology & Medicine,2021,第3期 HaihuaTian，JinchangPan，ShuaiFang，ChengweiZhou，HuiTian，JinxianHe，WeiyuShen，XiaodanMeng，XiaofengJin，ZhaohuiGong（Department of Biochemistry and Molecular Biology,Ningbo University School of Medicine；Zhejiang Province Key Laboratory of Pathophysiology,Ningbo University School of Medicine；Department of Thoracic Surgery,The Affiliated Hospital of Ningbo University School of Medicine；Department of Thoracic Surgery,The Affiliated Lihuili Hospital of Ningbo University）.LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients[J].Cancer Biology & Medicine,2021,第3期 TingZhang，XinruiYang，WanpingXu，JingWang，DaweiWu，ZhixianHong，ShengxianYuan，ZhenZeng，XiaodongJia，ShanshanLu，RifaatSafadi，SenHan，ZhihongYang，LeonardM.Neckers，SuthatLiangpunsakul，WeipingZhou，YinyingLu（Department of the Fifth Medical Center,General Hospital of PLA；Division of Gastroenterology and Hepatology,Department of Medicine,Indiana University School of Medicine；Urologic Oncologic Branch，Center for Cancer Research,National Cancer Institute；State Key Laboratory of Toxicology and Medical Countermeasures,Beijing Institute of Pharmacology and Toxicology；The Third Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital；Hadassah Medical Organization,Hadassah Hebrew University Medical Center；Department of Biochemistry and Molecular Biology,Indiana University School of Medicine；Center for Synthetic and Systems Biology （CSSB）,Tsinghua University）.Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy[J].Cancer Biology & Medicine,2021,第3期 RosariaA.Fontanella，SilviaSideri，ChiaraDiStefano，AngiolinaCatizone，SilviaDiAgostino，DanielaF.Angelini，GisellaGuerrera，LucaBattistini，GiuliaBattafarano，AndreaDelFattore，AntonioFrancescoCampese，FabrizioPadula，PaolaDeCesaris，AntonioFilippini，AnnaRiccioli（Department of Anatomy,Histology,Forensic Medicine and Orthopaedics,Unit of Histology and Medical Embryology，Sapienza University；Department of Health Sciences School of Medicine – "Magna Graecia" University of Catanzaro；IRCCS Fondazione Santa Lucia；Bone Physiopathology Research Unit，Genetics and Rare Diseases Research Division,Bambino Gesù Children’s Hospital，IRCCS；Department of Molecular Medicine,Sapienza University；Department of Life,Health and Environmental Sciences，University of L’Aquila）.CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells[J].Cancer Biology & Medicine,2021,第3期 XinWang，ZifeiPei，AasmaHossain，YutingBai，GongChen（Department of Biology,Huck Institutes of Life Sciences,Pennsylvania State University,University Park；GHM Institute of CNS Regeneration,Jinan University）.Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion[J].Cancer Biology & Medicine,2021,第3期 YongqiaoHe，DaweiYang，TingZhou，WenqiongXue，JiangboZhang，FangfangLi，FangWang，TongminWang，ZiyiWu，YingLiao，MeiqiZheng，ChangmiDeng，DanhuaLi，YijingJia，LeileiYuan，WenliZhang，WeihuaJia（Department of Radiation Oncology,Affiliated Cancer Hospital & Institute of Guangzhou Medical University；State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine，Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,Sun Yat-sen University Cancer Center；School of Public Health,Sun Yat-sen University；Department of Medical Oncology,Sun Yat-sen University Cancer Center）.Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients[J].Cancer Biology & Medicine,2021,第3期 JuxianSun，JiayiWu，ChangLiu，JieShi，YonggangWei，JianyinZhou，ZhiboZhang，WanYeeLau，MaolinYan，ShuqunCheng（Department of Hepatic Surgery Ⅵ,The Eastern Hepatobiliary Surgery Hospital,Second Military Medical University；Shengli Clinical Medical College,Fujian Medical University；Department of Hepatobiliary Surgery,Fujian Provincial Hospital；Department of Hepatobiliary Surgery,West China Hospital,Sichuan University；Department of Hepatobiliary Surgery,Zhongshan Hospital，Xiamen University；Department of Hepatobiliary Surgery,The First Affiliated Hospital of Fujian Medical University；Faculty of Medicine,The Chinese University of Hong Kong）.Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma[J].Cancer Biology & Medicine,2021,第3期 LisiZeng，QuanxingLiao，HaoranZhao，ShengweiJiang，XianziYang，HongshengTang，QingjunHe，XianshengYang，ShuxianFang，JinfuHe，WeiwenCui，LaiqiangHuang，ShaohuaMa，ShuzhongCui（Institute of Oncology,Affiliated Cancer Hospital and Institute of Guangzhou Medical University；Department of Abdominal Surgery,Affiliated Cancer Hospital and Institute of Guangzhou Medical University；Institute of Biopharmaceutical and Health Engineering,Shenzhen International Graduate School,Tsinghua University；Tsinghua-Berkeley Shenzhen Institute （TBSI）,Tsinghua University；Shenzhen Key Laboratory of Gene and Antibody Therapy,Tsinghua University；Department of Medical Oncology,Affiliated Cancer Hospital and Institute of Guangzhou Medical University；Department of Bioengineering,University of California）.Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids[J].Cancer Biology & Medicine,2021,第3期 ChenxiLi，YongmeiZhou，YiwenDeng，XueminShen，LinjunShi，WeiLiu（Department of Oral Mucosal Diseases,Shanghai Ninth People’s Hospital,Shanghai Jiao Tong University School of Medicine，College of Stomatology,Shanghai Jiao Tong University，National Center for Stomatology,National Clinical Research Center for Oral Diseases,Shanghai Key Laboratory of Stomatology；Department of Oral and Maxillofacial-Head and Neck Oncology,Shanghai Ninth People’s Hospital,Shanghai Jiao Tong University School of Medicine）.Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry[J].Cancer Biology & Medicine,2021,第3期首页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表